Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Liver cancer » Stats
 

Statistics about Liver cancer

Prevalence and incidence statistics for Liver cancer:

See also prevalence and incidence page for Liver cancer

Incidence (annual) of Liver cancer: 16,600 annual cases (SEER 2002 estimate)

Incidence Rate: approx 1 in 16,385 or 0.01% or 16,600 people in USA [about data]

Incidence extrapolations for USA for Liver cancer: 16,599 per year, 1,383 per month, 319 per week, 45 per day, 1 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the incidence statistic: 16,600 annual cases (SEER 2002 estimate)

Liver cancer: Rare Disease Status

Liver cancer is listed as a "rare disease" by the Office of Rare Diseases (ORD)...more »

Incidence statistics about Liver cancer:

The following statistics relate to the incidence of Liver cancer:

  • 18,920 new cases for liver/intrahepatic bile duct cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 12,580 new male cases for liver/intrahepatic bile duct cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 6,340 new female cases for liver/intrahepatic bile duct cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Liver cancer and intrahepatic bile duct cancer incidence by race and gender group in the USA:
    • 7.3 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.0 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 21.1 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 6.1 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 13.8 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 2.8 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 3.9 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 7.7 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 5.5 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 5.6 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • Liver cancer incidence statistics for men in various countries:
    • 44.5 men per 100,000 population with liver cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 35 men per 100,000 population with liver cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 19 men per 100,000 population with liver cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 7.3 men per 100,000 population with liver cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 4.9 men per 100,000 population with liver cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 4.1 men per 100,000 population with liver cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 4.1 men per 100,000 population with liver cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 3.9 men per 100,000 population with liver cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 3.7 men per 100,000 population with liver cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 3.6 men per 100,000 population with liver cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 3.0 men per 100,000 population with liver cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 2.5 men per 100,000 population with liver cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • Liver cancer incidence statistics for women in various countries:
    • 11.9 women per 100,000 population with liver cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 9.7 women per 100,000 population with liver cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 4.8 women per 100,000 population with liver cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 3.0 women per 100,000 population with liver cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 2.5 women per 100,000 population with liver cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 2.5 women per 100,000 population with liver cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 2.3 women per 100,000 population with liver cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 2.0 women per 100,000 population with liver cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 1.8 women per 100,000 population with liver cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 1.8 women per 100,000 population with liver cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 1.3 women per 100,000 population with liver cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 1.2 women per 100,000 population with liver cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • more about incidence...»

Death and mortality statistics for Liver cancer:

Deaths from Liver cancer: 12.382 deaths reported in USA 1999 for cancer of liver and intrahepatic bile ducts (NVSR Sep 2001)

Death rate extrapolations for USA for Liver cancer: 12 per year, 1 per month, 0 per week, 0 per day, 0 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the deaths statistic: 12.382 deaths reported in USA 1999 for cancer of liver and intrahepatic bile ducts (NVSR Sep 2001)

Death statistics for Liver cancer:

The following are statistics from various sources about deaths and Liver cancer:

  • 14,270 estimated deaths for liver/intrahepatic bile duct cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 9,450 estimated male deaths for liver/intrahepatic bile duct cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 4,820 estimated female deaths for liver/intrahepatic bile duct cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Liver and Intrahepatic Bile Duct Cancer mortality rates for race and gender groups in the USA:
    • 6 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 9.3 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 16.1 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 7.6 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 10.5 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 2.7 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 3.7 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 6.7 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 4.3 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 5 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 1.3% of all male deaths was due to liver disease in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 918 men died from liver disease in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • more about deaths...»

Survival rate statistics for Liver cancer:

The following are statistics from various sources about the survival rate for Liver cancer:

  • 7% of white people survive 5 years for liver cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5% of African American people survive 5 years for liver cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 7% survive 5 years for liver cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 6% of people with liver and intrahepatic cancer survive after 5 years in the US 1983-90 (SEER)
  • 5-year survival rate for black people with liver and intrahepatic cancer is 4.0% in the US 1983-90 (SEER)
  • 5-year survival rate for people with liver and intrahepatic cancer is 6.0% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with liver and intrahepatic cancer is 6.6% in the US 1983-90 (SEER)
  • more about deaths...»

Life Expectancy & Years of Life Lost for Liver cancer

Average life years lost for Liver cancer: 16.0 years for liver/IBD cancers (SEER)1

Society statistics for Liver cancer

Hospitalization statistics for Liver cancer:

The following are statistics from various sources about hospitalizations and Liver cancer:

  • 0.05% (6,423) of hospital consultant episodes were for malignant neoplasm of liver and intrahepatic bile ducts in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 80% of hospital consultant episodes for required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 62% of hospital consultant episodes for malignant neoplasm of liver and intrahepatic bile ducts were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 38% of hospital consultant episodes for malignant neoplasm of liver and intrahepatic bile ducts were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 35% of hospital consultant episodes for required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 11.2 days was the mean length of stay in hospitals for malignant neoplasm of liver and intrahepatic bile ducts in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 6 days was the median length of stay in hospitals for malignant neoplasm of liver and intrahepatic bile ducts in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 58 was the mean age of patients hospitalised for malignant neoplasm of liver and intrahepatic bile ducts in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 28% of hospital consultant episodes for malignant neoplasm of liver and intrahepatic bile ducts occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 26% of hospital consultant episodes for malignant neoplasm of liver and intrahepatic bile ducts occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 20% of hospital consultant episodes for malignant neoplasm of liver and intrahepatic bile ducts were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.08% (43,275) of hospital bed days were for malignant neoplasm of liver and intrahepatic bile ducts in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

About statistics:

This page presents a variety of statistics about Liver cancer. The term 'prevalence' of Liver cancer usually refers to the estimated population of people who are managing Liver cancer at any given time. The term 'incidence' of Liver cancer refers to the annual diagnosis rate, or the number of new cases of Liver cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes: 1. SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise